Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Carrot, Quidel, Ortho Clinical Diagnostics, Uvision360.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Bardy Diagnostics, Dariohealth, Hillrom, Histosonics, Tada Medical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Beigene, Bluebird, Humanigen, Innovent, Lysogene.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 48Hour, ABL, Aim Immunotech, Algernon, Arctic, Biocopy, Biological E, Biomarck, Bionomics, Biophytis, Camp4, Clionix, Daré, Dynavax, Eureka, Fastback, GT, Hummingbird, Ico, Immatics, Inceptor, Infectopharm, Innovent, Inveniai, Kedrion, Kymera, Laekna, Liminal, M8, Marinomed, MD Anderson, Medexus, Medac, Memorial Sloan Kettering, Moderna, Nicox, Novamind, Nrx, Nymirum, Ocumension, Open Orphan, Opko, Pierre Fabre, Polpharma, Poxel, Q Biomed, Rayzebio, SAB, Sanofi, Seelos, Servier, Sinovac, Sosei, Stallergenes, Surrozen, Teva, Thetis, Trevena, University Of Minnesota, Y-biologics.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aim Immunotech, Applied Molecular Transport, Arcutis, Ascendis, Bausch + Lomb, Bacainn, Biocryst, Evgen, Galapagos, Hansa, Janssen, Mediwound, Molecular Templates, Morphic, Ocugen, Oryzon, Pharnext, Rakuten, Reithera, Rhovac, Seelos, Summit, Takeda.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Eurofins, Lazurite, J&J, Mission Bio, Quantumdx, Rite Aid, Sequanta Technologies.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Alerje, Beacon, Bioasis, Biogen, Biontech, Bridgebio, Codexis, Corat, Cybin, Cyclerion, Dermapharm, Ensysce, Exscientia, ICER, I-Mab, Immorna, Ischemix, J&J, Janssen, Medolife, Neox Biotech, NMD, Pfizer, Puretech, Sunshine, Quanta, Virpax, Vor.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Aicuris, Akston, Astrazeneca, Atyr, Can-Fite, Daiichi Sankyo, Evaxion, Jiangsu Nhwa, Oncopeptides, Prilenia, Sellas, Trevena.